Published 2 days ago • loading... • Updated 2 days ago

Khondrion Announces First Patient Dosed in Phase II Study Targeting Debilitating Post-COVID Fatigue

Summary by WBOC 16

SON4PEM trial advances development of sonlicromanol, aiming to address chronic fatigue in Post-COVID patients with

+3 Reposted by 3 other sources

SON4PEM trial advances development of sonlicromanol, aiming to address chronic fatigue in Post-COVID patients with

2 days ago

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources4

Leaning Left1Leaning Right0Center2Last Updated2 days agoBias Distribution

67% Center

67% Center

Untracked bias

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

WBOC 16 broke the news 2 days ago on Tuesday, May 19, 2026.

Sources are mostly out of (0)